High-Dose Vitamin D Induction in Optic Neuritis

Summary

High-Dose Vitamin D Induction in Optic Neuritis is a clinical trial^[1].

Key Facts

• High-Dose Vitamin D Induction in Optic Neuritis is in the country of Canada^[2].
• High-Dose Vitamin D Induction in Optic Neuritis's instance of is recorded as clinical trial^[3].
• High-Dose Vitamin D Induction in Optic Neuritis's start time is recorded as +2017-11-23T00:00:00Z^[4].
• High-Dose Vitamin D Induction in Optic Neuritis's end time is recorded as +2022-11-30T00:00:00Z^[5].
• High-Dose Vitamin D Induction in Optic Neuritis's main subject is recorded as optic neuritis^[6].
• High-Dose Vitamin D Induction in Optic Neuritis's main subject is recorded as neuritis^[7].
• High-Dose Vitamin D Induction in Optic Neuritis's number of participants is recorded as {'unit': '1', 'amount': '+66'}^[8].
• High-Dose Vitamin D Induction in Optic Neuritis's title is recorded as A Phase II Trial of High-Dose Vitamin D Induction in Optic Neuritis (VitaDON 2)^[9].
• High-Dose Vitamin D Induction in Optic Neuritis's short name is recorded as VitaDON2^[10].
• High-Dose Vitamin D Induction in Optic Neuritis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• High-Dose Vitamin D Induction in Optic Neuritis's ClinicalTrials.gov ID is recorded as NCT03302585^[12].
• High-Dose Vitamin D Induction in Optic Neuritis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[13].
• High-Dose Vitamin D Induction in Optic Neuritis's research intervention is recorded as (5R)-24,25-Dihydroxyvitamin D^[14].
• High-Dose Vitamin D Induction in Optic Neuritis's clinical trial phase is recorded as phase II clinical trial^[15].
• High-Dose Vitamin D Induction in Optic Neuritis's research site is recorded as University of Calgary^[16].
• High-Dose Vitamin D Induction in Optic Neuritis's study type is recorded as interventional study^[17].